Mrv0541 05041403512D 19 20 0 0 1 0 999 V2000 3.2987 -2.7597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4744 1.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0687 -1.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0130 -0.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3281 1.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6580 0.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4013 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8138 1.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4013 0.0023 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.1717 2.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9888 1.8096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.7338 -1.3076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9888 -2.0922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8138 -2.0922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1359 -0.9699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7070 3.2345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9944 2.6145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.1446 0.3603 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 1.7027 -0.4366 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 6 2 2 0 0 0 0 6 4 1 0 0 0 0 7 3 2 0 0 0 0 8 5 2 0 0 0 0 9 6 1 0 0 0 0 9 7 1 6 0 0 0 10 8 1 0 0 0 0 11 2 1 0 0 0 0 11 8 1 0 0 0 0 12 7 1 0 0 0 0 13 12 2 0 0 0 0 14 1 1 0 0 0 0 14 3 1 0 0 0 0 14 13 1 0 0 0 0 15 4 2 0 0 0 0 16 10 2 0 0 0 0 17 10 1 0 0 0 0 18 5 1 0 0 0 0 18 9 1 0 0 0 0 9 19 1 1 0 0 0 M END > DB02816 > drugbank > [H][C@@]1(SC=C(NC=C1C=O)C(O)=O)C1=CN(C)N=N1 > InChI=1S/C10H10N4O3S/c1-14-3-7(12-13-14)9-6(4-15)2-11-8(5-18-9)10(16)17/h2-5,9,11H,1H3,(H,16,17)/t9-/m0/s1 > BCPHJDLBOJMWOD-VIFPVBQESA-N > C10H10N4O3S > 266.276 > 266.047360896 > 6 > 28 > -1.013722679189981 > 24.724553089220514 > 1 > 2 > 0 > 0 > (7S)-6-formyl-7-(1-methyl-1H-1,2,3-triazol-4-yl)-4,7-dihydro-1,4-thiazepine-3-carboxylic acid > -0.10 > -0.797800233333333 > -2.13 > 0 > -1 > 2 > -1 > 8.856355542206975 > 5.140965373893893 > 0.03359694279359287 > 97.11 > 77.73659999999998 > 3 > 1 > 1.99e+00 g/l > tetrahydrofolic acid > 0 > DB02816 > EXPT01416 > experimental > 7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem $$$$